Sapir Venture Partners

Enzymit is focused on transforming global manufacturing by advancing cell-free bio-production technology, which aims to reduce reliance on scarce resources and enhance sustainability. The company develops novel enzymes using artificial intelligence and deep learning algorithms, enabling the creation of innovative molecular machines that can convert abundant feedstocks into valuable products across various sectors, including pharmaceuticals, cosmetics, food, and materials. By employing small, modular bio-reactors, Enzymit enhances efficiency, reduces costs, and minimizes environmental impact compared to traditional whole-cell bio-production methods. This approach not only fosters resource independence but also allows for greater flexibility in product customization, positioning Enzymit as a competitive alternative to conventional chemical manufacturing.

DeepCure Inc. specializes in drug discovery services powered by artificial intelligence. The company employs advanced algorithms for De-novo Lead Discovery, which analyzes drug candidates from a virtual library, and utilizes AI-driven Lead Optimization to enhance drug development processes. Additionally, DeepCure's proprietary database, MoIDB, is designed to maximize the scale, diversity, and synthesizability of the chemical search space. Founded in 2018 and based in Boston, Massachusetts, DeepCure aims to accelerate the development of innovative, first-in-class precision therapeutics that address unmet medical needs. The company combines deep learning algorithms with cloud computing to improve pre-clinical drug development, ultimately assisting scientists and healthcare professionals in creating more effective therapeutic molecules for various disease targets.

Miter is set out to fix bad meetings. The company provides its users with a specific, outcome-oriented, shared goal and a simple list of topics for meetings. Milter aims to help motivated people improve their meetings and make better use of their teams' time and energy.

OUR MISSION Fabric is on a mission to create a world where everyone belongs, one in-person interaction at a time. We do this by augmenting shared experiences, starting with the number one industry that brings people together: Sports. OUR TEAM Fabric’s team is a diverse group of technologists, entrepreneurs, humanists, executives, mathematicians, and designers who are devoted to creating a world where everyone belongs through the creation of the world’s most accessible and innovative technology platform. OUR PLATFORM Fabric is a venture-backed geospatial web3 platform for sports teams and leagues. Our platform transforms the fan experience by delivering immersive real-time AR, blockchain, social, and gaming experiences, powered by no-code tools and an AI engine that understands the team’s needs. Fabric Spaces transform smartphones into an interactive and social 3D jumbotron in every fan's pocket, unlocking a new layer of the in-stadium experience. Fabric transports fans to the unlimited possibilities that come from the blending of physical and digital worlds all under the official banner of their favorite team. We call this the Reality-First Metaverse™, where fans join the team.

Diptera.ai, based in Jerusalem, Israel, specializes in innovative mosquito control solutions. The company focuses on a biological method that utilizes sterile insect techniques, specifically by releasing sterile male mosquitoes through a ready-to-use module over a period of weeks. This technology incorporates advanced optics, computer vision, and artificial intelligence, making it both affordable and accessible for municipal corporations. By eliminating the need for mosquito rearing and sorting facilities, Diptera.ai enables large-scale mosquito control efforts, addressing public health concerns efficiently.

Enzymit is focused on transforming global manufacturing by advancing cell-free bio-production technology, which aims to reduce reliance on scarce resources and enhance sustainability. The company develops novel enzymes using artificial intelligence and deep learning algorithms, enabling the creation of innovative molecular machines that can convert abundant feedstocks into valuable products across various sectors, including pharmaceuticals, cosmetics, food, and materials. By employing small, modular bio-reactors, Enzymit enhances efficiency, reduces costs, and minimizes environmental impact compared to traditional whole-cell bio-production methods. This approach not only fosters resource independence but also allows for greater flexibility in product customization, positioning Enzymit as a competitive alternative to conventional chemical manufacturing.

Gabriel is focused on enhancing safety and security through an innovative network of devices designed to address threats such as active shooter situations. In light of the increasing safety concerns globally, the company has developed a comprehensive alert and crisis management system that is user-friendly, easily deployable, and cost-effective. Their primary targets are schools and public buildings, where a combination of smart sensors and software facilitates instant alerts and offers essential communication and management tools. This approach enables communities to better prepare for and respond to potential dangers, while being significantly more affordable than existing solutions.

Strattic converts CMS-based websites into serverless versions, making them faster, scalable, and virtually unhackable. It disconnects the dynamic WordPress site from the web and puts it on a different URL behind authentication so only site owners can access that site. Site owners can continue using their WordPress like they always have – marketing people can still add content, owners can still add plugins, and so on. Then, site owners can deploy their site with one click of a button and changes get deployed as a static site with HTML, CSS, and Javascript, essentially the front-end of the site without the underlying vulnerabilities.

NeuoKaire, previously known as Genetika+, is focused on advancing personalized medical testing for the treatment of depression. The company has developed a platform that utilizes biological, medical, and genetic data, along with innovative technology, to identify the most effective drug therapies for individual patients. This approach aims to facilitate faster treatment, minimize side effects, and reduce dosages. By assisting pharmaceutical companies in differentiating their products and de-risking clinical trials, NeuoKaire enhances the identification of responsive patients and improves stratification. The integration of stem-cell technology, genomics, and artificial intelligence further supports the optimization of treatments for psychiatric and neurological disorders, ultimately aiming to transform care and improve patient outcomes.

CaliberMind is a developer of a B2B customer data platform designed to enhance the effectiveness of revenue marketers. The platform offers a range of features, including marketing attribution, engagement scoring, and insights into sales funnels and pipeline conversion points. It also provides tools for data integration, account engagement, and marketing workflow automation, allowing companies to leverage their sales, marketing, and customer data more effectively. By doing so, CaliberMind aims to help businesses optimize productivity, improve customer engagement, and ultimately increase revenue.

Lance is a smart business banking account for the self-employed built by and for freelancers to proactively manage their backend finances. It understands the world of freelancers has become a juggling act across client management platforms and financial services - with backend tools still built for SMB needs. Freelancers deserve a mobile-first, intuitive delivery of the finances they care about the most today and the community guidance to help them grow into the future.

Goodlight is a risk analytics platform focused on identifying potential issues within the workforce of organizations. By employing digital technology and machine learning, the platform assesses the dynamic risk profiles of employees after hiring, monitoring various data sources for anomalies. This proactive approach allows Goodlight to alert clients to early signs of employee risk, ultimately helping them mitigate potential workforce-related risks and reduce the costs associated with such incidents.

DeepCure Inc. specializes in drug discovery services powered by artificial intelligence. The company employs advanced algorithms for De-novo Lead Discovery, which analyzes drug candidates from a virtual library, and utilizes AI-driven Lead Optimization to enhance drug development processes. Additionally, DeepCure's proprietary database, MoIDB, is designed to maximize the scale, diversity, and synthesizability of the chemical search space. Founded in 2018 and based in Boston, Massachusetts, DeepCure aims to accelerate the development of innovative, first-in-class precision therapeutics that address unmet medical needs. The company combines deep learning algorithms with cloud computing to improve pre-clinical drug development, ultimately assisting scientists and healthcare professionals in creating more effective therapeutic molecules for various disease targets.

SynVaccine Ltd. is a biotechnology company based in Tel Aviv, Israel, focused on developing preventive viral vaccines targeting major human pathogens. Founded in 2013 by Tuval Ben Yehezkel, the company utilizes innovative technologies that facilitate the computational design of viral genomes and the physical editing of viral vaccine genome libraries. This approach enables SynVaccine to create effective vaccine candidates aimed at addressing significant health challenges posed by viral infections.

ConsortiaTX, Inc. is a seed stage, pre-clinical bio-therapeutics company that emerged from research laboratories at Brigham & Women’s Hospital and Children’s Hospital in Boston. The company’s intellectual property around food allergies and the human gut microbiome is based on the work of Lynn Bry, M.D., Ph.D., Georg Gerber, M.D., Ph.D. (both at BWH), and Talal Chatilla, Ph.D. (at CHB) and others.

PlanetWatchers, Inc. is a company based in San Francisco, California, that specializes in a platform for geospatial analytics focused on natural asset monitoring. Founded in 2016, PlanetWatchers provides a software-as-a-service solution designed for enterprises, governments, and NGOs across various sectors, including forestry, oil and gas. The company leverages advanced machine learning algorithms and synthetic aperture radar (SAR) technology to transform extensive manual data collection into rapid automated analysis. This capability enables organizations to efficiently monitor their natural assets, delivering critical insights that support the management of large-scale resources and enhance decision-making processes. By utilizing multi-source satellite sensors and elastic cloud infrastructure, PlanetWatchers facilitates effective monitoring and alerting systems that are essential for sectors such as crop insurance, improving accuracy and efficiency in claims validation.